AMID Co., June 2009, Pages: 195
. PHARMACEUTICAL PACKAGING MARKETS OUTLOOK
China’s Pharmaceutical Packaging Demand
VI. MARKETING STRATEGIES
China’s Distribution Channel
ChineseMarkets for Pharmaceutical Packaging
Frost & Sullivan, Oct 2010, Pages: 125
This research service titled Strategic Analysis of ChinesePharmaceutical Excipients Markets lists market trends, opportunities, and other pertinent research on pharmaceutical excipients. It also
Frost & Sullivan, Jan 2005
research service offers an exhaustive strategic analysis of the opportunities for European pharmaceutical and biotechnology companies in Indian and Chinesemarkets. Market drivers, restraints, and industry
JZMed Inc., May 2011, Pages: 230
is a must-read book to all global pharmaceutical and biotechnology companies seeking marketing opportunities in China and collaboration with Chinese drug companies, venture capital investors interested
Decision Resources, Inc., Aug 2011 pharmaceuticalmarkets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) will grow from 19 million in 2010 to 20.7 million in 2020, an increase of 9% in ten years. Many of these patients
Business Insights, Jan 2011, Pages: 96
. Rising cost pressures compounded with economic crisis have continued to drive pharmaceutical companies to seek the cost advantages offered by Chinese CMOs.Developing finished dose exports to developed
Decision Resources, Inc., Aug 2011
economies. Pharmaceutical companies mostly prioritize Brazil, Russia, India, China, Mexico, and Turkey (BRIC-MT) for their emerging market strategies. Two of these markets, China and India, are in developing
GBI Research, Sep 2011, Pages: 85
that shape the Chinesepharmaceutical market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry
Research In China, Dec 2010, Pages: 52
has many chemical pharmaceutical manufacturers, and the whole industry features a low concentration rate in general. However, the segmented markets have a higher concentration rate affected
Decision Resources, Inc., Jan 2010, Pages: 46
Will sufficient numbers of Midsize Pharma companies exist in this decade to feed the business development strategies of the pharmaceutical industry? The group of pharmaceutical companies known
Pharmalicensing Ltd., March 2006, Pages: 28
pharmaceutical industry
2.3. The structure of the Chinesepharmaceutical industry
2.3.1. Industry output
2.3.2. Import and export
2.3.3. The industry layout
2.4. R&D in China
2.5. Marketing approvals
Venn Research Inc., Aug 2010, Pages: 135
-2009. In comparison, the Chinese and South Korean markets grew with CAGRs of 20.1% and 7% respectively, over the same period, to reach respective values of $23,796.9 million and $9,603.3 million in 2009
Access China Management Consulting Ltd, May 2009, Pages: 41
The Chinesepharmaceutical industry has increased with an annual average growth rate of 16.72% over the last few decades. However, the industry is still small-scale, with a scattered geographical
Draco Healthcare Consulting LLC, Oct 2009, Pages: 55
The total Chinesepharmaceutical market had reached RMB 828.36 billion (US$ 120.84 billion, at an exchange rate of US $1 = RMB 6.83) with an annual growth rate (AGR) of 26.50% in 2008. The growth
JZMed Inc., Jan 2011, Pages: 282
market but also the Chinese companies in the industry so attractive to many foreign companies that are interested in seeking partnership for co-developing or marketing their products in China. The current
Business Insights, Dec 2010, Pages: 215
Emerging markets have represented important growth opportunities for the global pharmaceutical industry, but it has been unclear the extent to which this has been accompanied by growth in domestic
Taiyou Research, Nov 2011, Pages: 240
China has one of the world's top ten largest pharmaceuticalmarkets. The pharmaceutical industry in China is a booming sector as it covers not only pharmaceutical drugs, but also synthetic chemicals
Pacific Bridge Medical, Jan 2012, Minutes: 60
Steps to get Reimbursement
- Post-marketing surveillance and quality control
- Intellectual Property
This webcast is designed for professionals who want to be current on the Chinesepharmaceutical
Research In China, Dec 2010, Pages: 52
has many chemical pharmaceutical manufacturers, and the whole industry features a low concentration rate in general. However, the segmented markets have a higher concentration rate affected
